Selected research
Industry Research
Whole Plasmid Sequencing Industry Research Report 2026
Market perspective
The global Whole Plasmid Sequencing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Whole Plasmid Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Whole Plasmid Sequencing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Whole Plasmid Sequencing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Whole Plasmid Sequencing include Eurofins Genomics, GenScript, Plasmidsaurus, Genewiz, Macrogen Europe, Source BioScience, Psomagen, BaseClear B.V. and Molecular Cloning Laboratories (MCLAB), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Whole Plasmid Sequencing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Whole Plasmid Sequencing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Whole Plasmid Sequencing Market by Company
Eurofins Genomics
GenScript
Plasmidsaurus
Genewiz
Macrogen Europe
Source BioScience
Psomagen
BaseClear B.V.
Molecular Cloning Laboratories (MCLAB)
Polyplus
Elim Biopharm
SnapGene
Full Circle Labs
Unveil Bio
Microsynth AG
CD Genomics
Whole Plasmid Sequencing Segment by Type
Plasmid Regular (2.5 – 25 kb)
Plasmid Large (25 – 125 kb)
Plasmid XL (125 – 300 kb)
Others
Whole Plasmid Sequencing Segment by Application
Biopharmaceutical Companies
Research Institutions
Others
Whole Plasmid Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Plasmid Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Whole Plasmid Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Plasmid Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Whole Plasmid Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plasmid Regular (2.5 – 25 kb)
- Plasmid Large (25 – 125 kb)
- Plasmid XL (125 – 300 kb)
- Others
Applications
- Biopharmaceutical Companies
- Research Institutions
- Others
Companies covered
- Eurofins Genomics
- GenScript
- Plasmidsaurus
- Genewiz
- Macrogen Europe
- Source BioScience
- Psomagen
- BaseClear B.V.
- Molecular Cloning Laboratories (MCLAB)
- Polyplus
- Elim Biopharm
- SnapGene
- Full Circle Labs
- Unveil Bio
- Microsynth AG
- CD Genomics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Whole Plasmid Sequencing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Plasmid Regular (2.5 – 25 kb)
- 2.2.3 Plasmid Large (25 – 125 kb)
- 2.2.4 Plasmid XL (125 – 300 kb)
- 2.2.5 Others
- 2.3 Whole Plasmid Sequencing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceutical Companies
- 2.3.3 Research Institutions
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Whole Plasmid Sequencing Breakdown Data by Type
- 3.1 Global Whole Plasmid Sequencing Historic Market Size by Type (2021-2026)
- 3.2 Global Whole Plasmid Sequencing Forecasted Market Size by Type (2027-2032)
4 Whole Plasmid Sequencing Breakdown Data by Application
- 4.1 Global Whole Plasmid Sequencing Historic Market Size by Application (2021-2026)
- 4.2 Global Whole Plasmid Sequencing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Whole Plasmid Sequencing Market Perspective (2021-2032)
- 5.2 Global Whole Plasmid Sequencing Growth Trends by Region
- 5.2.1 Global Whole Plasmid Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Whole Plasmid Sequencing Historic Market Size by Region (2021-2026)
- 5.2.3 Whole Plasmid Sequencing Forecasted Market Size by Region (2027-2032)
- 5.3 Whole Plasmid Sequencing Market Dynamics
- 5.3.1 Whole Plasmid Sequencing Industry Trends
- 5.3.2 Whole Plasmid Sequencing Market Drivers
- 5.3.3 Whole Plasmid Sequencing Market Challenges
- 5.3.4 Whole Plasmid Sequencing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Whole Plasmid Sequencing Players by Revenue
- 6.1.1 Global Top Whole Plasmid Sequencing Players by Revenue (2021-2026)
- 6.1.2 Global Whole Plasmid Sequencing Revenue Market Share by Players (2021-2026)
- 6.2 Global Whole Plasmid Sequencing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Whole Plasmid Sequencing Head Office and Area Served
- 6.4 Global Whole Plasmid Sequencing Players, Product Type & Application
- 6.5 Global Whole Plasmid Sequencing Manufacturers Established Date
- 6.6 Global Whole Plasmid Sequencing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Whole Plasmid Sequencing Market Size (2021-2032)
- 7.2 North America Whole Plasmid Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 7.4 North America Whole Plasmid Sequencing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Whole Plasmid Sequencing Market Size (2021-2032)
- 8.2 Europe Whole Plasmid Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 8.4 Europe Whole Plasmid Sequencing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Whole Plasmid Sequencing Market Size (2021-2032)
- 9.2 Asia-Pacific Whole Plasmid Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Whole Plasmid Sequencing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Whole Plasmid Sequencing Market Size (2021-2032)
- 10.2 South America Whole Plasmid Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 10.4 South America Whole Plasmid Sequencing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Whole Plasmid Sequencing Market Size (2021-2032)
- 11.2 Middle East & Africa Whole Plasmid Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Whole Plasmid Sequencing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Genomics
- 12.1.1 Eurofins Genomics Company Information
- 12.1.2 Eurofins Genomics Business Overview
- 12.1.3 Eurofins Genomics Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.1.4 Eurofins Genomics Whole Plasmid Sequencing Product Portfolio
- 12.1.5 Eurofins Genomics Recent Developments
- 12.2 GenScript
- 12.2.1 GenScript Company Information
- 12.2.2 GenScript Business Overview
- 12.2.3 GenScript Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.2.4 GenScript Whole Plasmid Sequencing Product Portfolio
- 12.2.5 GenScript Recent Developments
- 12.3 Plasmidsaurus
- 12.3.1 Plasmidsaurus Company Information
- 12.3.2 Plasmidsaurus Business Overview
- 12.3.3 Plasmidsaurus Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.3.4 Plasmidsaurus Whole Plasmid Sequencing Product Portfolio
- 12.3.5 Plasmidsaurus Recent Developments
- 12.4 Genewiz
- 12.4.1 Genewiz Company Information
- 12.4.2 Genewiz Business Overview
- 12.4.3 Genewiz Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.4.4 Genewiz Whole Plasmid Sequencing Product Portfolio
- 12.4.5 Genewiz Recent Developments
- 12.5 Macrogen Europe
- 12.5.1 Macrogen Europe Company Information
- 12.5.2 Macrogen Europe Business Overview
- 12.5.3 Macrogen Europe Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.5.4 Macrogen Europe Whole Plasmid Sequencing Product Portfolio
- 12.5.5 Macrogen Europe Recent Developments
- 12.6 Source BioScience
- 12.6.1 Source BioScience Company Information
- 12.6.2 Source BioScience Business Overview
- 12.6.3 Source BioScience Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.6.4 Source BioScience Whole Plasmid Sequencing Product Portfolio
- 12.6.5 Source BioScience Recent Developments
- 12.7 Psomagen
- 12.7.1 Psomagen Company Information
- 12.7.2 Psomagen Business Overview
- 12.7.3 Psomagen Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.7.4 Psomagen Whole Plasmid Sequencing Product Portfolio
- 12.7.5 Psomagen Recent Developments
- 12.8 BaseClear B.V.
- 12.8.1 BaseClear B.V. Company Information
- 12.8.2 BaseClear B.V. Business Overview
- 12.8.3 BaseClear B.V. Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.8.4 BaseClear B.V. Whole Plasmid Sequencing Product Portfolio
- 12.8.5 BaseClear B.V. Recent Developments
- 12.9 Molecular Cloning Laboratories (MCLAB)
- 12.9.1 Molecular Cloning Laboratories (MCLAB) Company Information
- 12.9.2 Molecular Cloning Laboratories (MCLAB) Business Overview
- 12.9.3 Molecular Cloning Laboratories (MCLAB) Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.9.4 Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Product Portfolio
- 12.9.5 Molecular Cloning Laboratories (MCLAB) Recent Developments
- 12.10 Polyplus
- 12.10.1 Polyplus Company Information
- 12.10.2 Polyplus Business Overview
- 12.10.3 Polyplus Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.10.4 Polyplus Whole Plasmid Sequencing Product Portfolio
- 12.10.5 Polyplus Recent Developments
- 12.11 Elim Biopharm
- 12.11.1 Elim Biopharm Company Information
- 12.11.2 Elim Biopharm Business Overview
- 12.11.3 Elim Biopharm Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.11.4 Elim Biopharm Whole Plasmid Sequencing Product Portfolio
- 12.11.5 Elim Biopharm Recent Developments
- 12.12 SnapGene
- 12.12.1 SnapGene Company Information
- 12.12.2 SnapGene Business Overview
- 12.12.3 SnapGene Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.12.4 SnapGene Whole Plasmid Sequencing Product Portfolio
- 12.12.5 SnapGene Recent Developments
- 12.13 Full Circle Labs
- 12.13.1 Full Circle Labs Company Information
- 12.13.2 Full Circle Labs Business Overview
- 12.13.3 Full Circle Labs Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.13.4 Full Circle Labs Whole Plasmid Sequencing Product Portfolio
- 12.13.5 Full Circle Labs Recent Developments
- 12.14 Unveil Bio
- 12.14.1 Unveil Bio Company Information
- 12.14.2 Unveil Bio Business Overview
- 12.14.3 Unveil Bio Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.14.4 Unveil Bio Whole Plasmid Sequencing Product Portfolio
- 12.14.5 Unveil Bio Recent Developments
- 12.15 Microsynth AG
- 12.15.1 Microsynth AG Company Information
- 12.15.2 Microsynth AG Business Overview
- 12.15.3 Microsynth AG Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.15.4 Microsynth AG Whole Plasmid Sequencing Product Portfolio
- 12.15.5 Microsynth AG Recent Developments
- 12.16 CD Genomics
- 12.16.1 CD Genomics Company Information
- 12.16.2 CD Genomics Business Overview
- 12.16.3 CD Genomics Revenue in Whole Plasmid Sequencing Business (2021-2026)
- 12.16.4 CD Genomics Whole Plasmid Sequencing Product Portfolio
- 12.16.5 CD Genomics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst